Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04755777
Status:
COMPLETED
Last Update Posted:
2023-02-21
First Post:
2021-02-10
Brief Title:
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill a Multicenter Mixed-methods Study
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to characterize various healthcare practitioners perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None